Charway, Grace N.A.
(Inland and Aquaculture Division, Fisheries Commission, Ministry of Fisheries and Aquaculture Development)
,
Yenumula, Padmini
(Department of Food Science and Technology, Pukyong National University)
,
Kim, Young-Mog
(Inland and Aquaculture Division, Fisheries Commission, Ministry of Fisheries and Aquaculture Development)
해양생물에는 육상생물자원에서는 존재하지 않는 다양한 화합물이 많이 존재하는데 이들 화합물은 새로운 치료제 및 대체 치료법을 개발하는데 유용하게 이용될 수 있다. 현재 해조류의 다양한 생리활성에 대한 연구가 진행되고 있으며 최근에는 여러 병원성 및 인체 감염균에 대한 항균효과를 나타내어 신약개발의 보고로 다양한 연구가 진행이 되고있다. 즉, 해조류는 천연물신약 또는 새로운 치료제 개발에 중요한 생물자원이다.
해양생물에는 육상생물자원에서는 존재하지 않는 다양한 화합물이 많이 존재하는데 이들 화합물은 새로운 치료제 및 대체 치료법을 개발하는데 유용하게 이용될 수 있다. 현재 해조류의 다양한 생리활성에 대한 연구가 진행되고 있으며 최근에는 여러 병원성 및 인체 감염균에 대한 항균효과를 나타내어 신약개발의 보고로 다양한 연구가 진행이 되고있다. 즉, 해조류는 천연물신약 또는 새로운 치료제 개발에 중요한 생물자원이다.
The world is becoming overwhelmed with widespread diseases as antibiotic resistance increases at an alarming rate. Hence, there is a demanding need for the discovery and development of new antimicrobial drugs. The ocean is gifted with many organisms like phytoplankton, algae, sponges, cnidarians, br...
The world is becoming overwhelmed with widespread diseases as antibiotic resistance increases at an alarming rate. Hence, there is a demanding need for the discovery and development of new antimicrobial drugs. The ocean is gifted with many organisms like phytoplankton, algae, sponges, cnidarians, bryozoans, mollusk, tunicates and echinoderms, which are known to produce a wide variety of bioactive secondary metabolites with pharmacological properties. Many new therapeutic drugs have emerged from marine invertebrates, although the large algal community is yet to be explored. The bioactivity possessing secondary metabolites of marine algae include polyphenols, phlorotannins, alkaloids, halogenated compounds, sulfated polysaccharides, agar, carrageenan, proteoglycans, alginate, laminaran, rhamnan sulfate, galactosylglycerol, and fucoidan. These metabolites have been found to have great antimicrobial activities against many human aliments. Studies show that the algal community represents about 9% of biomedical compounds obtained from the sea. This review looks at the evolution of drugs from the ocean, with a special emphasis on the antimicrobial activities of marine algae.
The world is becoming overwhelmed with widespread diseases as antibiotic resistance increases at an alarming rate. Hence, there is a demanding need for the discovery and development of new antimicrobial drugs. The ocean is gifted with many organisms like phytoplankton, algae, sponges, cnidarians, bryozoans, mollusk, tunicates and echinoderms, which are known to produce a wide variety of bioactive secondary metabolites with pharmacological properties. Many new therapeutic drugs have emerged from marine invertebrates, although the large algal community is yet to be explored. The bioactivity possessing secondary metabolites of marine algae include polyphenols, phlorotannins, alkaloids, halogenated compounds, sulfated polysaccharides, agar, carrageenan, proteoglycans, alginate, laminaran, rhamnan sulfate, galactosylglycerol, and fucoidan. These metabolites have been found to have great antimicrobial activities against many human aliments. Studies show that the algal community represents about 9% of biomedical compounds obtained from the sea. This review looks at the evolution of drugs from the ocean, with a special emphasis on the antimicrobial activities of marine algae.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
문제 정의
Recently, a great deal of interest has been expressed regarding marine algae as potential antiviral agents. This contribution focuses on anti-herpes virus therapeutic agents derived from marine algae which are considered as novel functional ingredients in anti-herpes virus therapy. Sulfated polymannuroguluronate (SPMG) a polysaccharide with an average molecular weight of 8.
성능/효과
Studies showed that Dictyotapfaffii and Canistrocarpuscervicornis, brown alga have an antileishmanial activity and that the diterpene [8,10,18-trihydroxy-2,6-dolabelladiene(5)] obtained from Dictyotapfaffii, exhibited a leishmanicidal activity against intracellular amastigotes (IC50= 44 µM) and anti-human immunodeficiency virus (HIV)-1 activity.
참고문헌 (54)
Donia M., Hamann M.T.: Marine natural products and their potential applications as anti-infective agents. Lancet Infect. Dis., 6, 338-348 (2003).
Lie J., Zhou J.: A marine natural product database. J. Chem. Inf. Comput. Sci., 42, 742-748 (2002).
Barbosa M., Valentao P., Andrade P.B.: Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases. Mar. Drugs, 12, 4934-4972 (2014).
Farias W.R., Valente A.P., Pereira M.S., Mourao P.A.: Structure and anticoagulant activity of sulfated galactans. Isolation of a unique sulfated galactan from the red algae Botryocladiaoccidentalis and comparison of its anticoagulant action with that of sulfated galactans from invertebrates. J. Biol. Chem., 275, 29299-2307 (2000).
Nuijen B., Bouma M., Talsma H., Manada C., Jimeno J.M., Lopez-Lazaro L., Bult A., Beijnen J.H.: Development of a lyophilized parenteral pharmaceutical formulation of the investigational polypeptide marine anticancer agent kahalalide F. Drug Dev. Ind. Pharm., 27, 767-780 (2000).
Palermo J.A., Flower B.P., Seldes A.M.: Chondriamides A and B new indolic metabolites from red algae Chondria sp. Tetrahedron Lett., 33, 3097-3100 (1992).
Davyt D., Entz W., Fernandez R., Mariezcurrena R., Mombru A.W., Saldana J., Dominguez L., Coll J., Manta E.: A new indole derivative from the red alga Chondriaatropurpurea. Isolation, structure determination, and anthelmintic activity. J. Nat. Prod., 61, 1560-1563 (1998).
Hidari K.I., Takahashi N., Arihara M., Nagaoka M., Morita K., Suzuki T.: Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem. Biophys. Res. Commun., 376, 91-95 (1981).
Shibata T., Fujimoto K., Nagayama K., Yamaguchi K., Nakamura T.: Inhibitory activity of brown algal phlorotannins against hyaluronidase. Int. J. Food Sci. Tech., 37, 703-709 (2002).
Bernardi G. and Springer G.F.: Properties of highly purified fucan. J. Biol. Chem., 237, 75-80 (1962).
Yuan H., Song J., Li X., Li N., Dai J.: Immunomodulation and antitumor activity of ${\kappa}$ -carrageenan oligosaccharides. Cancer Lett., 243, 228-234 (2006).
Woolner V.H., Jones C.M., Field J.J., Fadzilah N.H., Munkacsi A.B., Miller J.H., Keyzers R.A., Northcote P.T.: Polyhalogenated indoles from the red alga Rhodophyllis-membranacea: The first isolation of bromo-chloro-iodo secondary metabolites. J. Nat. Prod., 79, 463-469 (2016).
de Sousa A.P.A., Torres M.R., Pessoa C., deMoraes M.O., Filho F.D.R., Alves A.P.N.N., Costa-Lotufo L.V.: In vivo growth-inhibition of sarcoma 180 tumor by alginates from brown seaweed Sargassum vulgare. Carbohydr. Polym., 69, 7-13 (2007).
Bourgougnon N., Lahaye M., Quemener B., Chermann J.C., Rimbert M., Cormaci M., Furnari G., Komprobst J.M.: Annual variation in composition and in vitro anti-HIV-1 activity of the sulfated glucuronogalactan from Schizymeniadubyi (Rhodophyta, Gigartinales). J. Appl. Phycol., 8, 155-161 (1996).
Rajasulochana P., Krishnamoorthy P., Dhamotharan R.: Isolation, identification of bromophenol compound and antibacterial activity of Kappaphycus sp. Int. J. Pharm. Bio. Sci., 3, 173-186 (2012).
Torres F.A.E., Passalacqua T.G., Velasquez A.M.A., Souza R.A., Colepicolo P., Graminha M.A.S.: New drugs with antiprotozoal activity from marine algae: a review. Rev. Bras. Farmacog., 24, 265-276 (2014).
Guedes A.C., Barbosa C.R., Helena M.A., Claudia I.P., Francisco, X.M.: Microalgal and cyanobacterial cell extracts for use as natural antibacterial additives against food pathogens. Int. J. Food Sci. Technol., 46, 862-870 (2011).
Cavallo R.A., Acquaviva M.I., Stabili L., Cecere E., Petrocelli A., Narracci M.: Antibacterial activity of marine macroalgae against fish pathogenic Vibrio species. Cent. Eur. J. Biol., 8, 646 (2013).
Demirel Z., Yilmaz-Koz F.F., Karabay-Yavasoglu U.N., Ozdemir G., Sukatar A.: Antimicrobial and antioxidant activity of brown algae from the Aegean Sea. J. Ser. Chem. Soc., 74, 619-628 (2009).
Bhagavathy S., Sumathi P., Jancy Sherene Bell I.: Green algae Chlorococcumhumicola a new source of bioactive compounds with antimicrobial activity. Asian Pac. J. Trop. Biomed., 1, S1-7 (2011).
Plaza M., Santoyo S., Jaime L, Garcia-Blairsy R.G., Herrero M., Senorans F.J., Ibanez E.: Screening for bioactive compounds from algae. J. Pharm. Biomed. Anal., 51, 450-455 (2010).
Manilal A., Sujith S., Selvin J., Shakir C., Seghal G.: Antibacterial activity of Falkenbergiahillebrandii (Born) from the Indian coast against human pathogens. Int. J. Exp. Bot., 78, 161-166, (2009).
Etahiri S., Bultel-Ponce V., Caux C., Guyot M.: New bromoditerpenes from the red alga Sphaerococcuscoronopifolius. J. Nat. Prod., 64, 1024-1027 (2001).
Cueto M., Jensen P.R., Kauffman P., Fenical W., Lobkovsky E., Clardy J.: Pestalone a new antibiotic produced by a marine fungus in response to bacterial challenge. J. Nat. Prod., 64, 1444-1446 (2001).
Eom S.H., Lee D.S., Kang Y.M., Son K.T., Jeon Y.J., Kim Y.M.: Application of yeast Candida utilis to ferment Eiseniabicyclis for enhanced antibacterial effect. Appl. Biochem. Biotechnol., 171, 569-582 (2013).
Alarif W.M., Al-Lihaibi S.S., Ayyad S.E., Abdel-Rhman M.H., Badria F.A.: Laurene-type sesquiterpenes from the Red Sea red alga Laurenciaobtusa as potential antitumoreantimicrobial agents. Eur. J. Med. Chem., 55, 462-466 (2012).
Lee M.H., Lee K.B., Oh S.M., Lee B.H., Chee H.Y.: Antifungal activities of dieckol isolated from the marine brown alga Ecklonia cava against Trichophyton rubrum. Food Sci. Biotechnol., 53, 504-507 (2010).
da Silva Machado F.L., Pacienza-Lima W., Rossi-Bergmann B., de Souza Gestinari L.M., Fujii M.T. de Paula J.C., Costa S.S., Lopes N.P., Kaiser C.R., Soares, A.R.: Antileishmanialsesquiterpenes from the brazilian red alga Laurenciadendroidea. Planta Med., 77, 733-735 (2011).
dos Santos A.O., Britta E.A., Bianco E.M., Ueda-Nakamura T., Filho B.P., Pereira R.C., Nakamura C.V.: 4-Acetoxydolastane diterpene from the Brazilian brown alga Canistrocarpuscervicornis as antileishmanial agent. Mar. Drugs, 9, 2369-2383 (2011).
dos Santos A.O., Veiga-Santos P., Ueda-Nakamura T., Sudatti D.B., Bianco E.M., Pereira R.C., Nakamura C.V.: Effect of elatol, isolated from red seaweed Laurenciadendroidea, on Leishmaniaamazonensis. Mar. Drugs, 8, 2733-2743 (2010).
Vonthron-Senecheau C., Kaiser M., Devambez I., Vastel A., Mussio I., Rusig A.M.: Antiprotozoal activities of organic extracts from French marine seaweeds. Mar. Drugs, 9, 922-933 (2011).
Galle J.B., Attioua B., Kaiser M., Rusig A.M., Lobstein A., Vonthron-Senecheau C.: Eleganolone, a diterpene from the French marine alga Bifurcariabifurcata inhibits growth of the human pathogens Trypanosoma brucei and Plasmodium falciparum. Mar. Drugs, 11, 599-610 (2013).
Suzgec-Selcuk S., Mericli A.H., Guven K.C., Kaiser M., Casey R., Hingley-Wilson S., Lalvani A., Tasdemir D.: Evaluation of Turkish seaweeds for antiprotozoal, antimycobacterial and cytotoxic activities. Phytother. Res., 25, 778-783 (2011).
de Felicio R., de Albuquerque S., Young M.C., Yokoya N.S., Debonsi H.M.: Trypanocidal, leishmanicidal and antifungal potential from marine red alga Bostrychiatenella J. Agardh (Rhodomelaceae, Ceramiales). J. Pharm. Biomed. Anal., 52, 763-769 (2010).
Ono L., Wollinger W., Rocco I.M., Coimbra T.L., Gorin P.A., Sierakowski M.R.: In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain). Antiviral Res., 60, 201-208 (2003).
Beress A., Wassermann O., Tahhan S., BruhnT., Beress L., Kraiselburd E.N., Gonzalez L.V., de Motta G.E., Chavez P.I.: A new procedure for the isolation of anti-HIV compounds (polysaccharides and polyphenols) from the marine alga Fucusvesiculosus. J. Nat. Prod., 56, 478-488 (1993).
※ AI-Helper는 부적절한 답변을 할 수 있습니다.